Abstract
AbstractInterim analysis is a common methodology in randomised clinical trials but has received less attention in studies of diagnostic test accuracy. In such studies, early termination for futility may be beneficial if early evidence indicates that a diagnostic test is unlikely to achieve a clinically useful level of diagnostic performance, as measured by the sensitivity and specificity. In this paper, we describe relevant practical and analytical considerations when planning and performing interim analysis in diagnostic accuracy studies, focusing on stopping rules for futility. We present an adaptation of the exact group sequential method for diagnostic testing, with R code provided for implementing this method in practice. The method is illustrated using two simulated data sets and data from a published diagnostic accuracy study for point-of-care testing for SARS-CoV-2. The considerations described in this paper can be used to guide decisions as to when an interim analysis in a diagnostic accuracy study is suitable and highlight areas for further methodological development.
Funder
National Institute for Health and Care Research
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Thompson M, Van den Bruel A. Diagnostic tests toolkit. BMJ Books; 2012.
2. Zhou XH, Obuchowski NA, McClish DK. 3: design of diagnostic accuracy studies. In: Statistical Methods in Diagnostic Medicine. Wiley; 2011.
3. National Institute for Health and Care Excellence. Early Value Assessment (EVA) for medtech. 2023. https://www.nice.org.uk/about/what-we-do/eva-for-medtech. Accessed 13 Nov 2023.
4. Gerke O, Høilund-Carlsen PF, Poulsen MH, Vach W. Interim analyses in diagnostic versus treatment studies: differences and similarities. Am J Nucl Med Mol Imaging. 2012;2:344–52.
5. Zapf A, Stark M, Gerke O, Ehret C, Benda N, Bossuyt P, et al. Adaptive trial designs in diagnostic accuracy research. Stat Med. 2019;39:591–601.